Cargando…
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions
During the past few years, our understanding of molecular mechanisms and cellular interactions relevant to malignant blood cell disorders has improved substantially. New insights include a detailed knowledge about disease-initiating exogenous factors, endogenous (genetic, somatic, epigenetic) elicit...
Autores principales: | Valent, Peter, Orfao, Alberto, Kubicek, Stefan, Staber, Philipp, Haferlach, Torsten, Deininger, Michael, Kollmann, Karoline, Lion, Thomas, Virgolini, Irene, Winter, Georg, Hantschel, Oliver, Kenner, Lukas, Zuber, Johannes, Grebien, Florian, Moriggl, Richard, Hoermann, Gregor, Hermine, Olivier, Andreeff, Michael, Bock, Christoph, Mughal, Tariq, Constantinescu, Stefan N., Kralovics, Robert, Sexl, Veronika, Skoda, Radek, Superti-Furga, Giulio, Jäger, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892291/ https://www.ncbi.nlm.nih.gov/pubmed/33623882 http://dx.doi.org/10.1097/HS9.0000000000000536 |
Ejemplares similares
-
Targeting allosteric regulatory modules in oncoproteins: “Drugging the Undruggable”
por: Hantschel, Oliver, et al.
Publicado: (2011) -
Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal()
por: Valent, Peter, et al.
Publicado: (2017) -
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML
por: Valent, Peter, et al.
Publicado: (2017) -
Cell biology: A key driver of therapeutic innovation
por: Hantschel, Oliver, et al.
Publicado: (2012) -
The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis
por: Mian, Afsar A., et al.
Publicado: (2019)